| 1 | DVBCWPW1 ;ALB/CMM PULMONARY TB AND MYCO. DIS. WKS TEXT - 1 ; 6 MARCH 1997
 | 
|---|
| 2 |  ;;2.7;AMIE;**12**;Apr 10, 1995
 | 
|---|
| 3 |  ;
 | 
|---|
| 4 |  ;
 | 
|---|
| 5 | TXT ;
 | 
|---|
| 6 |  ;;A.  Review of Medical Records:
 | 
|---|
| 7 |  ;;
 | 
|---|
| 8 |  ;;
 | 
|---|
| 9 |  ;;
 | 
|---|
| 10 |  ;;B.  Medical History (Subjective Complaints):
 | 
|---|
| 11 |  ;;
 | 
|---|
| 12 |  ;;    Comment on:
 | 
|---|
| 13 |  ;;    1.  Activity of pulmonary tuberculosis or other mycobacterial disease.
 | 
|---|
| 14 |  ;;
 | 
|---|
| 15 |  ;; 
 | 
|---|
| 16 |  ;;    2.  Date of inactivity if it is not active.
 | 
|---|
| 17 |  ;;
 | 
|---|
| 18 |  ;;
 | 
|---|
| 19 |  ;;    3.  Identity of organism (if possible).
 | 
|---|
| 20 |  ;;
 | 
|---|
| 21 |  ;;
 | 
|---|
| 22 |  ;;C.  Physical examination (Objective Findings):
 | 
|---|
| 23 |  ;;
 | 
|---|
| 24 |  ;;    Address each of the following and fully describe current findings:
 | 
|---|
| 25 |  ;;    1.  Extent of structural damage to lungs.
 | 
|---|
| 26 |  ;;
 | 
|---|
| 27 |  ;;
 | 
|---|
| 28 |  ;;    2.  If patient was hospitalized for 6 months or more, what is the
 | 
|---|
| 29 |  ;;        condition at the end of hospitalization?
 | 
|---|
| 30 |  ;;
 | 
|---|
| 31 |  ;;
 | 
|---|
| 32 |  ;;    3.  If patient was hospitalized for 12 months or more, what is the
 | 
|---|
| 33 |  ;;        condition at the end of hospitalization?
 | 
|---|
| 34 |  ;;
 | 
|---|
| 35 |  ;;
 | 
|---|
| 36 |  ;;D.  Diagnostic and Clinical Tests:
 | 
|---|
| 37 |  ;;
 | 
|---|
| 38 |  ;;    Provide:
 | 
|---|
| 39 |  ;;    Pulmonary Function Tests, if indicated. When the results of 
 | 
|---|
| 40 |  ;;    pre-bronchodilator pulmonary function tests are NORMAL, post-
 | 
|---|
| 41 |  ;;    bronchodilator studies are not required for VA evaluation purposes.  
 | 
|---|
| 42 |  ;;    IN ALL OTHER CASES, post-bronchodilator studies shuld be conducted
 | 
|---|
| 43 |  ;;    unless contraindicated (because of allergy to medication, etc.) or
 | 
|---|
| 44 |  ;;    if the veteran was on bronchodilators before the test and had taken 
 | 
|---|
| 45 |  ;;    his or her medication within a few hours of the study.  An examiner 
 | 
|---|
| 46 |  ;;    who determines that a post-bronchodilator study should not be 
 | 
|---|
| 47 |  ;;    performed should provide an explanation of why not.  If there is 
 | 
|---|
| 48 |  ;;    a disparity between the results of different pulmonary function 
 | 
|---|
| 49 |  ;;    tests (FEV-1, FVC, etc.), the examiner should indicate which test
 | 
|---|
| 50 |  ;;    result is the best indicator of the veteran's level of pulmonary 
 | 
|---|
| 51 |  ;;    functioning.
 | 
|---|
| 52 |  ;;
 | 
|---|
| 53 |  ;;
 | 
|---|
| 54 |  ;;E.  Diagnosis:
 | 
|---|
| 55 |  ;;
 | 
|---|
| 56 |  ;;    In reactivated cases, is this reactivation of the old disease or a
 | 
|---|
| 57 |  ;;    separate and distinct new infection.  
 | 
|---|
| 58 |  ;;
 | 
|---|
| 59 |  ;;
 | 
|---|
| 60 |  ;;
 | 
|---|
| 61 |  ;;ADDITIONAL NOTE TO THE PHYSICIAN:
 | 
|---|
| 62 |  ;;In all claims, if the disease is inactive and if the inactivity was 
 | 
|---|
| 63 |  ;;confirmed at a non-VA facility, obtain the name and mailing address of
 | 
|---|
| 64 |  ;;the facility from the veteran so that the Regional Office may request
 | 
|---|
| 65 |  ;;the report.
 | 
|---|
| 66 |  ;;
 | 
|---|
| 67 |  ;;
 | 
|---|
| 68 |  ;;Signature:                             Date:
 | 
|---|
| 69 |  ;;END
 | 
|---|